Approval · Notice of Compliance 36705 · 2026
POTELIGEO: Notice of Compliance 36705
Issued January 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36705
- Date
- January 8, 2026
- Company
- Kyowa Kirin, Inc.Princeton, New Jersey, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POTELIGEO | Not yet assigned | — |
Medicinal ingredients
- MOGAMULIZUMAB 4 MG per ML